AI assistant
Tempest Therapeutics, Inc. — Director's Dealing 2013
Jun 11, 2013
34632_dirs_2013-06-11_f3397be5-da09-4169-afd1-7ee9cbe68da0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2013-06-07
Reporting Person: Deer Management Co. LLC (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-07 | Stock Option (right to buy) | $14.00 | A | 4448 | Acquired | 2023-06-07 | Common Stock (4448) | Indirect |
Footnotes
F1: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 7, 2013.
F2: Stephen Kraus, an employee of the Reporting Person, serves as the representative of the entities affiliated with the Reporting Person on the Issuer's board of directors and is contractually obligated to assign any fees received for service as a director to the Reporting Person, pursuant to which obligation, the Reporting Person has the right to any shares issuable pursuant to this grant or any proceeds from the sale thereof.